AKR1B10 is Associated with Smoking and Smoking-related Non-small-cell Lung Cancer

Author： Kang M-W   Lee E-S   Yoon SY   Jo J   Lee J   Kim HK   Choi YS   Kim K   Shim YM   Kim J   Kim H  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.39, Iss.1, 2011-01, pp. : 78-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differences in driver genes between smoking-related and non–smoking-related lung cancer in the Chinese population

By GouLan-Ying   NiuFei-Yu   WuYi-Long   ZhongWen-Zhao  

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 3069-3079

Blackwell Publishing

Access to resources Recommend Favorite

Surfactant Proteins in Smoking-Related Lung Disease

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 14, 2016-06 ,pp. : 1574-1581

Bentham Science Publishers

Access to resources Recommend Favorite

Spotlight on Gefitinib in Non-Small-Cell Lung Cancer

By Frampton James E.   Easthope Stephanie E.  

American Journal of PharmacoGenomics, Vol. 5, Iss. 2, 2005-01 ,pp. : 133-136

Adis International

Access to resources Recommend Favorite

Vandetanib for the treatment of non-small-cell lung cancer

By Wong Hui-li   de Boer Richard H  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2271-2278

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for non-small-cell lung cancer

By Felip Enriqueta   Santarpia Mariacarmela   Rosell Rafael  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 3, 2007-09 ,pp. : 449-460

Informa Healthcare

Access to resources Recommend Favorite